Understand your brain. Optimise your potential.
Peer-reviewed neuroscience distilled into clear, actionable insights, covering nootropic peptides, cognitive performance, and brain longevity.
Featured Articles
All articlesGinkgo Biloba for Dementia and MCI: What the 2026 Cochrane Review Found
A February 2026 Cochrane systematic review pooled 82 trials and 10,613 participants to test ginkgo biloba against placebo in dementia, mild cognitive impairment, multiple sclerosis, and subjective memory complaints. The results differ sharply by population.
10 Plant Compounds, One Ranking: What a New Network Meta-Analysis Found on Cognition
A January 2026 network meta-analysis pooled 25 RCTs and 1,861 healthy older adults to rank bacopa, ginkgo, guarana, curcumin, raisin, tart cherry, and more head-to-head across five cognitive domains.
Lithium and the Aging Brain: The 2025 Deficiency Discovery and Why the Human Trials Still Say No
A 2025 Nature paper found that brain lithium falls early in Alzheimer's disease and that lithium orotate reversed pathology in mice. A late-2025 meta-analysis of six human trials and a 2026 Pittsburgh pilot trial of low-dose lithium carbonate both came back negative or inconclusive in people. Here is what each study actually found.
Latest Research
View allCoQ10 and Ubiquinol for Cognition: What a New Randomized Trial Found
A 2026 randomized trial from Swinburne University and the Baker Heart & Diabetes Institute tested 200 mg/day of ubiquinol against placebo in 111 older adults. Here is what it found on memory, processing speed, blood pressure, and arterial stiffness, and how it fits the mixed prior evidence.
Acetyl-L-Carnitine: What the Trial Evidence Shows for Mood and Cognition
A June 2026 meta-analysis found acetyl-L-carnitine matched antidepressants for mood symptoms. Here is what that review, the older dementia trials, a Cochrane review, and a 2025 genetic study actually show about its cognitive effects.
Exogenous Ketones and Cognition: What the 2026 Meta-Analysis of 29 Trials Found
A systematic review and meta-analysis in Frontiers in Nutrition pools 38 trials of ketone esters, MCT, and ketone salts against placebo. Here is what it found on cognitive performance, dose-response, and where the evidence is still thin.
Vinpocetine: What the Cognitive Evidence Shows and Why the FDA Says It Isn't a Supplement
Vinpocetine is a synthetic periwinkle derivative sold as a memory and circulation nootropic. Here is what the Cochrane review and the newest evidence synthesis actually found, and why the FDA has spent a decade arguing it should not be legally sold as a dietary supplement at all.
Science you can actually understand
4Neuroscience is an independent research hub synthesising peer-reviewed studies on nootropic peptides, cognitive neuroscience, and human performance, written for researchers, students, and health-conscious Australians.